Revelyx Bio

DE · Founded 2025 · Privately Held (backing)

Developer of a botulinum toxin liquid formulation designed to bring a new anti-aging and medical experience characterized by efficacy. Revelyx Bio is based in DE and was founded in 2025. Its last reported valuation was $110 million in Jan 2026. It has raised $10.4 million.

Last reported valuation
$109.5M
Oct 2026
Priced at
—
Total raised
$10.4M
Last round
—

Who backs Revelyx Bio?

1 investors
InvestorType
NRL CapitalOther
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Revelyx Bio investors

1 investor is on record for Revelyx Bio, including NRL Capital.

Free account
More of Revelyx Bio with a free account
  • ·Watch Revelyx Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 1 firms already write checks for companies like Revelyx Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View